gamma-delta T cell therapy (Shandong Province Qilu Stem Cells Engineering)

A cell therapy involving the adoptive transfer of gamma-delta (γδ) T cells, developed by Shandong Province Qilu Stem Cells Engineering. γδ T cells are a unique subset of T cells that bridge innate and adaptive immunity, recognizing stress-induced ligands on infected or malignant cells in a Major Histocompatibility Complex (MHC)-independent manner. Upon recognition of these ligands, the γδ T cells mediate direct cytotoxicity through the release of perforin and granzymes and produce pro-inflammatory cytokines to orchestrate a broader immune response. This therapy is offered as part of the company's clinical research and service portfolio, targeting conditions where stress-induced ligands are expressed, such as various cancers and infectious diseases.

Other names

gamma-delta T cellsγδT cellsgamma-delta T cell therapyγδT